Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
4E Therapeutics Inc. is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This specific action represents the current state of the company's patent prosecution. The presence of 1 pending office action suggests a concentrated effort to secure intellectual property rights within this technical domain.
The prosecution is managed through 1 distinct art unit and involves 1 distinct examiner. This concentration indicates that the company's current applications are being evaluated within a specific technical niche. For a practitioner, the involvement of 1 distinct examiner means that the prosecution strategy is not diversified across various perspectives at the patent office.
HEASLEY, MEGHAN CHRISTINE is the busiest examiner for this portfolio, with a busiest examiner pending count of 1. This examiner is responsible for the 1 pending office action currently active. The success of the company's pending matters is therefore tied to the examination requirements of HEASLEY, MEGHAN CHRISTINE. Practitioners should monitor the tendencies of HEASLEY, MEGHAN CHRISTINE to anticipate the next steps in the prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HEASLEY, MEGHAN CHRISTINE | 1 | 75.2% | +34.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18003829 | PYRIDINE-1,5-DIONES EXHIBITING MNK INHIBITION AND THEIR METHOD OF USE | HEASLEY, MEGHAN CHRISTINE | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18003829 | PYRIDINE-1,5-DIONES EXHIBITING MNK INHIBITION AND THEIR METHOD OF USE | HEASLEY, MEGHAN CHRISTINE | 1626 | §102§103DP | Non-Final OA | — | Pending | Dec 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial